What Is Jardiance 10 mg?
Jardiance 10 mg is an oral tablet containing 10 mg of empagliflozin. It belongs to a medicine group called sodium glucose cotransporter 2 inhibitors. The shorter name is SGLT2 inhibitors. These medicines reduce the amount of glucose returned to the blood by the kidneys.
Jardiance is used with diet and physical activity to manage type 2 diabetes. Empagliflozin also has specific uses in adults with heart failure and chronic kidney disease. The reason for treatment determines the dose and monitoring plan. These uses do not mean that every person with diabetes or kidney disease needs this medicine.
Boehringer Ingelheim markets the Jardiance brand. Each 10 mg tablet contains one active medicine. It does not contain metformin or insulin. Your clinician checks kidney function and hydration before prescribing it. The 10 mg strength is the usual starting dose and the recommended dose for heart failure and chronic kidney disease. KwickPharmacy's active ingredient directory helps explain how medicines are grouped by their ingredients.




